Advertisement

Topics

Atrin Pharmaceuticals Awarded $300,000 Phase 1 Contract for Development of Highly Specific ATR inhibitors for Targeted Cancer Treatment

04:48 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
DOYLESTOWN, Pa., Oct. 19, 2016 /PRNewswire/ --  Atrin Pharmaceuticals, Inc. today announced receipt of a Phase 1 Small Business Technology Transfer (STTR) Award (R41CA203436) for approximately $300,000 from the National Cancer Institute (NCI) of the N...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Atrin Pharmaceuticals Awarded $300,000 Phase 1 Contract for Development of Highly Specific ATR inhibitors for Targeted Cancer Treatment"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...